Efficacy and safety of anticoagulant therapy using Fondaparinux sodium and low molecular weight heparin for the treatment of acute myocardial syndrome: A Meta-analysis

doi:10.3969/j.issn.1672-5301.2015.08.006

Home>Articles>Efficacy and safety of anticoagulant therapy using Fondaparinux sodium and low molecular weight heparin for the treatment of acute myocardial syndrome: A Meta-analysis

DOI: 10.3969/j.issn.1672-5301.2015.08.006

Efficacy and safety of anticoagulant therapy using Fondaparinux sodium and low molecular weight heparin for the treatment of acute myocardial syndrome: A Meta-analysis

Keywords：Fondaparinux sodiumLow molecular weight heparinAnticoagulant therapyAcute myocardial syndromeEfficacySafety

Publication Date：2015-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 693-698 )

Chinese Journal of Cardiovascular Research

ISTIC

ISSN：1672-5301

Year, Vol.(Issue)：2015,13(8)